Therapixel’s MammoScreen analyses mammograms to help radiologists detect breast cancer earlier and cut reading time. It is used by hospitals and organised national breast screening programmes in Europe and the US.
AI mammography reading software for breast cancer screening programmes
This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
€15,000,000
Total raised
-
Valuation
51-200
Employees
2013
Founded
Latest round
Series B - May 1, 2022
Series B - €15,000,000
May 1, 2022
Elaia Omnes Capital
Open roles
Therapixel is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile